| Primary |
| Drug Use For Unknown Indication |
24.2% |
| Helicobacter Infection |
12.6% |
| Product Used For Unknown Indication |
11.9% |
| Bronchitis |
5.0% |
| Nasopharyngitis |
5.0% |
| Upper Respiratory Tract Inflammation |
4.7% |
| Hypertension |
4.1% |
| Constipation |
3.5% |
| Mycobacterium Avium Complex Infection |
3.5% |
| Pyrexia |
3.5% |
| Atypical Mycobacterial Infection |
3.1% |
| Disease Complication |
3.1% |
| Diabetes Mellitus |
2.5% |
| Upper Respiratory Tract Infection |
2.5% |
| Pneumonia Mycoplasmal |
2.2% |
| Prophylaxis |
1.9% |
| Renal Failure Chronic |
1.9% |
| Asthma |
1.6% |
| Infection |
1.6% |
| Leukocytoclastic Vasculitis |
1.6% |
|
| Interstitial Lung Disease |
11.7% |
| Liver Disorder |
10.0% |
| Pancytopenia |
10.0% |
| Enterocolitis Haemorrhagic |
6.7% |
| Stevens-johnson Syndrome |
6.7% |
| Drug-induced Liver Injury |
5.0% |
| Erythema Multiforme |
5.0% |
| Pseudomembranous Colitis |
5.0% |
| Renal Failure Acute |
5.0% |
| Drug Eruption |
3.3% |
| Leukocytoclastic Vasculitis |
3.3% |
| Pneumocystis Jirovecii Pneumonia |
3.3% |
| Pneumonia |
3.3% |
| Pouchitis |
3.3% |
| Rash |
3.3% |
| Septic Shock |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Ventricular Tachycardia |
3.3% |
| Vomiting |
3.3% |
| Bradycardia |
1.7% |
|
| Secondary |
| Bronchitis |
10.5% |
| Asthma |
10.2% |
| Drug Use For Unknown Indication |
8.6% |
| Atypical Mycobacterial Infection |
8.0% |
| Influenza |
8.0% |
| Helicobacter Infection |
6.8% |
| Nasopharyngitis |
5.2% |
| Pneumonia Legionella |
4.6% |
| Cough |
4.3% |
| Hypertension |
4.0% |
| Dyspnoea |
3.7% |
| Otitis Media Acute |
3.7% |
| Pneumonia |
3.4% |
| Epilepsy |
3.1% |
| Infection |
3.1% |
| Insomnia |
2.8% |
| Constipation |
2.5% |
| Diarrhoea |
2.5% |
| Hiv Infection |
2.5% |
| Mycobacterium Avium Complex Infection |
2.5% |
|
| Hepatitis Acute |
13.3% |
| Purpura |
11.7% |
| Erythema Multiforme |
10.0% |
| Liver Disorder |
8.3% |
| Interstitial Lung Disease |
5.0% |
| Pneumonia |
5.0% |
| Pyrexia |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Death |
3.3% |
| Dysgeusia |
3.3% |
| Hepatic Function Abnormal |
3.3% |
| Jaundice Cholestatic |
3.3% |
| Neutrophil Count Decreased |
3.3% |
| Pancytopenia |
3.3% |
| Rhabdomyolysis |
3.3% |
| Skin Induration |
3.3% |
| Torsade De Pointes |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Abnormal Behaviour |
1.7% |
| Acute Generalised Exanthematous Pustulosis |
1.7% |
|
| Concomitant |
| Rheumatoid Arthritis |
16.1% |
| Drug Use For Unknown Indication |
14.0% |
| Prophylaxis |
8.6% |
| Hypertension |
8.5% |
| Product Used For Unknown Indication |
8.5% |
| Plasma Cell Myeloma |
7.9% |
| Bronchitis |
4.6% |
| Asthma |
4.3% |
| Mycobacterium Avium Complex Infection |
3.9% |
| Pneumonia |
3.8% |
| Pyrexia |
2.3% |
| Atypical Mycobacterial Infection |
2.2% |
| Bronchitis Chronic |
2.2% |
| Constipation |
2.2% |
| Insomnia |
2.1% |
| Cough |
1.9% |
| Dementia Alzheimer's Type |
1.9% |
| Hiv Infection |
1.8% |
| Chronic Sinusitis |
1.7% |
| Diarrhoea |
1.7% |
|
| Pyrexia |
11.3% |
| Interstitial Lung Disease |
10.5% |
| Shock |
10.5% |
| White Blood Cell Count Decreased |
8.3% |
| Pneumonia |
6.8% |
| Cardiac Failure |
5.3% |
| Platelet Count Decreased |
5.3% |
| Respiratory Failure |
5.3% |
| Hepatic Function Abnormal |
4.5% |
| Rash |
4.5% |
| Death |
3.8% |
| Abnormal Behaviour |
3.0% |
| Decreased Appetite |
3.0% |
| Herpes Zoster |
3.0% |
| Lung Disorder |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Asthma |
2.3% |
| Bronchopneumonia |
2.3% |
| Drug Eruption |
2.3% |
| Eosinophilic Pneumonia |
2.3% |
|
| Interacting |
| Helicobacter Infection |
35.1% |
| Mycobacterium Test |
21.6% |
| Renal Transplant |
18.9% |
| Hiv Infection |
10.8% |
| Chronic Myeloid Leukaemia |
8.1% |
| Hypertension |
5.4% |
|
| Nephropathy Toxic |
58.3% |
| Neutrophil Count Decreased |
16.7% |
| Renal Disorder |
16.7% |
| Pleural Effusion |
8.3% |
|
